Anesthetic management of patients treated with antihypertensive agents of levodopa.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000758:Anesthesia / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011926:Rauwolfia / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013514:Surgical Procedures, Operative; D013565:Sympatholytics / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014703:Veratrum / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D013565:Sympatholytics; D013843:Thiazines; D014665:Vasodilator Agents; D013148:Spironolactone; D004295:Dihydroxyphenylalanine; D006145:Guanethidine